Page 2 - மருந்து வளர்ச்சி உச்சிமாநாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்து வளர்ச்சி உச்சிமாநாடு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்து வளர்ச்சி உச்சிமாநாடு Today - Breaking & Trending Today

Investegate |Oxurion NV Announcements | Oxurion NV: OXURION NV to Present at Wet AMD and DME Drug Development Summit

Investegate announcements from Oxurion NV, OXURION NV to Present at Wet AMD and DME Drug Development Summit ....

United States , Region Flamande , Grace Chang , Wouter Piepers , Sylvie Berrebi Frazer Hall , Christopher Brinzey , Citigate Dewe Rogerson , Bicycle Therapeutics , Participation In Panel Discussion , Corporate Communications , Drug Development Summit , Euronext Brussels , Chief Medical Officer , Development Summit , New Therapeutics Target , Plasma Kallikrein System , First Clinical , Targeting New Therapeutic Pathways , Looking Beyond , Panel Discussion , Topic Searching , Novel Therapeutic Targets , Addressing Developmental Challenges , New Drug Candidates , Investegate Announcements , Investegate Company Announcements ,

Oxurion NV: OXURION NV to Present at Wet AMD and DME Drug Development Summit

Leuven, BE, Boston, MA, US - April 13th, 2021 - 7.30 AM CET - Oxurion NV(Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard-of-care ophthalmic therapies, with a clinical ....

United States , Region Flamande , Grace Chang , Wouter Piepers , Sylvie Berrebi Frazer Hall , Christopher Brinzey , Citigate Dewe Rogerson , Bicycle Therapeutics , Participation In Panel Discussion , Corporate Communications , Drug Development Summit , Euronext Brussels , Chief Medical Officer , Development Summit , New Therapeutics Target , Plasma Kallikrein System , First Clinical , Targeting New Therapeutic Pathways , Looking Beyond , Panel Discussion , Topic Searching , Novel Therapeutic Targets , Developmental Challenges , New Drug Candidates , ஒன்றுபட்டது மாநிலங்களில் , கருணை சாங் ,

Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD & DME Drug Development Summit

Share:
ALPHARETTA, Ga., April 05, 2021 (GLOBE NEWSWIRE) Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will present at two upcoming virtual conferences in April 2021:
Needham Virtual Healthcare Conference
Monday, April 12, 2021 at 12:45 p.m. ET
The live and archived Needham Virtual Healthcare Conference presentation webcast may be accessed on the Clearside website under the Investors section: Events and Presentations.
Wet AMD & DME Drug Development Summit ....

Remy Bernarda , Thomasa Ciulla , Jenny Kobin , Drug Development Summit , Panel Discussion , Clearside Biomedical Inc , Chief Medical Officer , Chief Development Officer , Needham Virtual Healthcare Conference , Development Summit , Monthly Treatments , Drug Delivery , Potential Solution , Making Strides Forward , Media Contacts , Clearside Biomedical , மருந்து வளர்ச்சி உச்சிமாநாடு , குழு கலந்துரையாடல் , தலைமை மருத்துவ அதிகாரி , தலைமை வளர்ச்சி அதிகாரி , நீட்ஹாம் மெய்நிகர் சுகாதாரம் மாநாடு , வளர்ச்சி உச்சிமாநாடு , மாதாந்திர சிகிச்சைகள் , மருந்து டெலிவரி , பொடெந்ஶியல் தீர்வு , தயாரித்தல் முன்னேற்றங்கள் முன்னோக்கி ,

Poxel Reports Financial Results for Full Year 2020 and Provides Corporate Update

Poxel Reports Financial Results for Full Year 2020 and Provides Corporate Update
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

France General , New York , United States , South Korea , Arthur Rouill , Merck Serono , Thomas Kuhn , Sumitomo Dainippon Pharma , Valeria Fisher , Catherine David , Davide Moller , Japan Diabetes Society , Drug Development Summit , Takeda Chemical Industries Ltd , Early Stage Development , World Health Organization , Trophic Communications , Clinical Development Updates , Kempen Life Sciences Conference , Devices Agency , Financial Press , Imeglimin Phase , European Association , Diabetes Annual , Sumitomo Dainippon , Liver Meeting ,

Poxel Reports Financial Update for Cash and Revenue for the Full Year 2020 and Provides Corporate Update

Press release content from Business Wire. The AP news staff was not involved in its creation.
Poxel Reports Financial Update for Cash and Revenue for the Full Year 2020 and Provides Corporate Update
February 12, 2021 GMT
LYON, France (BUSINESS WIRE) Feb 12, 2021
POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced its cash position and revenue for the twelve months ended December 31, 2020 and provided a corporate update.
ADVERTISEMENT
“Despite the challenges posed by the COVID-19 pandemic, Poxel ended 2020 on a strong note, having accomplished several important corporate and clinical milestones and positioning the Company for an exciting 2021. We continued working closely with our partner Sumitomo Dainippon Pharma to further advance the review of the Japanese New Drug Applicatio ....

United States , South Korea , Arthur Rouill , Thomas Kuhn , Sumitomo Dainippon Pharma , Valeria Fisher , Stephena Harrison , Jonae Barnes , Japan Diabetes Society , Clinical Additional Development , Division Of Endocrinology , Drug Development Summit , University Of Florida , World Health Organization , Trophic Communications , Hc Wainwright Global Life Sciences Conference , Corporate Communications , Kempen Life Sciences Conference , Devices Agency , Financial Press , Department Of Medicine , Summit Clinical Research , Japanese New Drug Application , Dainippon Pharma , Sumitomo Dainippon , Imeglimin Phase ,